BSN medical Inc. Sustainability Profile
BSN medical Inc., a prominent player in the medical device industry, is headquartered in the United States and operates extensively across North America and Europe. Founded in 2001, the company has established itself as a leader in the development of innovative wound care, compression therapy, and orthopaedic products. BSN medical is renowned for its core offerings, including the popular JOBST® compression garments and the Cutimed® range of advanced wound care solutions, which are distinguished by their quality and effectiveness. The company has achieved significant milestones, including numerous industry awards that underscore its commitment to excellence and innovation. With a strong market position, BSN medical continues to set benchmarks in patient care, making it a trusted name among healthcare professionals and patients alike.
DitchCarbon Score
How does BSN medical Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
BSN medical Inc.'s score of 83 is higher than 91% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
BSN medical Inc., headquartered in the US, currently does not have specific carbon emissions data available for the most recent year, as indicated by the absence of reported figures. The company is a current subsidiary of Essity AB (publ), which means that any climate commitments or emissions data may be inherited from its parent organisation. As part of its climate strategy, BSN medical Inc. aligns with the sustainability initiatives of Essity AB (publ). This includes participation in the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP), both of which are aimed at reducing greenhouse gas emissions across the supply chain. However, specific reduction targets or achievements for BSN medical Inc. have not been disclosed. The absence of direct emissions data suggests that BSN medical Inc. is still in the process of establishing its own climate commitments or may rely on the broader corporate strategies set by Essity AB (publ). As a subsidiary, BSN medical Inc. is expected to contribute to the overarching sustainability goals of its parent company, which are designed to address climate change and reduce carbon footprints across all scopes of emissions.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 1,539,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
| Scope 2 | 1,819,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
| Scope 3 | 7,053,000,000 | - | - | - | - | - | 0,000,000,000 | 0,000,000,000 | - |
How Carbon Intensive is BSN medical Inc.'s Industry?
How Carbon Intensive is BSN medical Inc.'s Location?
BSN medical Inc.'s Scope 3 Categories Breakdown
BSN medical Inc.'s Scope 3 emissions, which decreased by 8% last year and decreased by approximately 13% since 2016, demonstrating supply chain emissions tracking. Most of their carbon footprint comes from suppliers and value chain emissions, with Scope 3 emissions accounting for 71% of total emissions under the GHG Protocol, with "End-of-Life Treatment of Sold Products" being the largest emissions source at 31% of Scope 3 emissions.
Top Scope 3 Categories
BSN medical Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
BSN medical Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
